We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-12.35%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$14.3B
AUM Growth
-$444M
(-3%)
Cap. Flow
+$1.68B
Cap. Flow
% of AUM
11.73%
Top 10 Holdings %
Top 10 Hldgs %
21.62%
Holding
1,821
New
56
Increased
555
Reduced
957
Closed
250
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$101M |
| 2 |
Amazon
AMZN
|
+$99.5M |
| 3 |
Microsoft
MSFT
|
+$95.8M |
| 4 |
Linde
LIN
|
+$84.2M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$40.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PX
Praxair Inc
PX
|
+$77.4M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$35.2M |
| 3 |
McCormick & Company Non-Voting
MKC
|
+$14.7M |
| 4 |
CA
CA, Inc.
CA
|
+$13.2M |
| 5 |
Clorox
CLX
|
+$12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Healthcare | 13.08% |
| 3 | Financials | 12.21% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Consumer Staples | 10.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Teledyne Technologies
TDY
$30.4B
| $530K | ﹤0.01% |
2,561
-608
| -19% | -$133K |
|
|
ESPR
927
DELISTED
Esperion Therapeutics
ESPR
| $529K | ﹤0.01% |
11,498
-2,232
| -16% | -$108K |
|
928
LiveRamp
RAMP
$2.29B
| $529K | ﹤0.01% |
13,704
-2,570
| -16% | -$116K |
|
|
ESGR
929
DELISTED
Enstar Group
ESGR
| $527K | ﹤0.01% |
3,142
-290
| -8% | -$52.5K |
|
|
PRSP
930
DELISTED
Perspecta Inc. Common Stock
PRSP
| $526K | ﹤0.01% |
30,545
-7,739
| -20% | -$171K |
|
|
ETRN
931
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $525K | ﹤0.01% |
+26,217
| New | +$553K |
|
932
Charles River Laboratories
CRL
$10.9B
| $521K | ﹤0.01% |
4,605
-1,057
| -19% | -$132K |
|
933
Planet Fitness
PLNT
$4.23B
| $521K | ﹤0.01% |
9,721
-1,638
| -14% | -$84K |
|
|
SGMO
934
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $520K | ﹤0.01% |
45,295
-8,571
| -16% | -$106K |
|
935
Targa Resources
TRGP
$60.4B
| $518K | ﹤0.01% |
14,389
+3,149
| +28% | +$152K |
|
936
Service Corp International
SCI
$11.4B
| $517K | ﹤0.01% |
12,851
-3,199
| -20% | -$139K |
|
937
CDW
CDW
$17.1B
| $515K | ﹤0.01% |
6,356
-4,173
| -40% | -$359K |
|
|
RPAI
938
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $515K | ﹤0.01% |
47,445
-3,406
| -7% | -$40.7K |
|
939
MKS Inc
MKSI
$22.2B
| $512K | ﹤0.01% |
7,927
-2,141
| -21% | -$155K |
|
|
NUVA
940
DELISTED
NuVasive, Inc.
NUVA
| $512K | ﹤0.01% |
10,337
-2,016
| -16% | -$121K |
|
941
Churchill Downs
CHDN
$6.03B
| $509K | ﹤0.01% |
12,516
-2,484
| -17% | -$110K |
|
942
PBF Energy
PBF
$7.29B
| $509K | ﹤0.01% |
15,582
-411
| -3% | -$16.6K |
|
943
Assured Guaranty
AGO
$3.78B
| $506K | ﹤0.01% |
13,222
-959
| -7% | -$38.3K |
|
|
BDN
944
Brandywine Realty Trust
BDN
$551M
| $506K | ﹤0.01% |
39,287
-2,039
| -5% | -$28.8K |
|
|
CIT
945
DELISTED
CIT Group Inc.
CIT
| $506K | ﹤0.01% |
13,222
-1,585
| -11% | -$71.9K |
|
946
CRISPR Therapeutics
CRSP
$4.58B
| $505K | ﹤0.01% |
17,665
-1,739
| -9% | -$60.5K |
|
947
DigitalBridge
DBRG
$2.94B
| $504K | ﹤0.01% |
26,900
-1,361
| -5% | -$31.1K |
|
|
CXP
948
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $503K | ﹤0.01% |
25,985
-1,351
| -5% | -$28.9K |
|
949
Cirrus Logic
CRUS
$6.74B
| $502K | ﹤0.01% |
15,118
-3,592
| -19% | -$133K |
|
950
IPG Photonics
IPGP
$3.89B
| $501K | ﹤0.01% |
4,423
+469
| +12% | +$62.3K |
|
Similar funds
ProShare Advisors's Q4 2018 Portfolio in Review
As of Q4 2018, ProShare Advisors held 1,821 positions worth $14.3B, down 3% from $14.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
ProShare Advisors deployed $1.68B of net new capital in Q4 2018, opening 56 new positions and adding to 555 existing holdings. Its largest new stake was Linde: 532,831 shares worth $83.1M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was McCormick & Company Non-Voting, an estimated $14.7M trimmed.
- ProShare Advisors's largest Q4 2018 buy was Linde: 532,831 shares worth $83.1M.
- ProShare Advisors added most to Apple in Q4 2018, an estimated $101M increase.
- ProShare Advisors's biggest Q4 2018 reduction was McCormick & Company Non-Voting, cutting an estimated $14.7M.
- ProShare Advisors fully exited Praxair Inc in Q4 2018, selling an estimated $77.4M.
- ProShare Advisors's ten largest holdings make up 22% of its $14.3B portfolio in Q4 2018.
- ProShare Advisors opened 56 new positions and closed 250 in Q4 2018.
- ProShare Advisors's portfolio value fell 3% quarter-over-quarter to $14.3B.
Based on ProShare Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.